Keywords: tobi, filed, europe, pathogenesis, uk, approval, market

TOBI Filed In Europe

Article | 20 August 1998

Print This

Pathogenesis has filed for UK approval to market its inhaled tobramycinproduct, sold as TOBI in the USA, for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in